Press Releases

This section and the included press releases are presented for historical purposes only. Press releases and other documents speak only as of the date thereof.

Date	Title
06/13/19	Novan to Participate in JMP Securities Life Sciences Conference
06/06/19	Novan Achieves Compliance with Nasdaq Listing Rule 5450(b)(2)(A)
06/04/19	First Patient Enrolled and Dosed in Novan’s SB206 Phase 3 Molluscum Program
05/31/19	Novan Announces 2019 Annual Meeting of Stockholders for July 31, 2019
05/07/19	Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
05/06/19	Novan Completes Funding Transaction with Ligand Pharmaceuticals
05/01/19	Novan Confirms Corporate Update Conference Call and Webcast
04/29/19	Novan Secures Up to $35 Million in Non-Dilutive Funding
03/19/19	Novan and Sato Advance Japan Market and Dermatology Partnership
03/11/19	Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
01/30/19	Novan Provides Business Update
01/02/19	Novan Announces Management Changes and Provides Business Update

Press Releases

Keyword Search